Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer

Neoplasma

Volumn 60, Issue 3, 2013, Pages 254-261

  Yang, B ^a   Gao, J ^a   Rao, Z ^a   Shen, Q ^b  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

CRC; Immunohistochemistry; MMP 14; Prognosis; Survival; 5 1 integrin

Indexed keywords

MATRIX METALLOPROTEINASE 14; VERY LATE ACTIVATION ANTIGEN 5; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR DIFFERENTIATION; VERY ELDERLY; ADENOCARCINOMA; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; METABOLISM; METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS; RECTUM;

ADENOCARCINOMA; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRIN ALPHA5BETA1; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 14; MIDDLE AGED; PROGNOSIS; RECTUM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84879392340     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_034     Document Type: Article

References (43)

1. BRETTHAUER M., KALAGER M. Colonoscopy as a Triage Screening Test. N ENGL J MED 2012; 366: 759-760. http://dx.doi.org/10.1056/NEJMe1114639
2. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, et al. Cancer statistics. CA Can-cer J Clin 2009; 59: 225-49. http://dx.doi.org/10.3322/caac.20006
3. BARDELLI A, SIENA S. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 2010; 28: 1254-61. http://dx.doi.org/10.1200/JCO.2009.24.6116
4. O'CONNELL, J.B., MAGGARD, M.A., KO, C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl. Cancer Inst. 2004; 96: 1420-1425. http://dx.doi.org/10.1093/jnci/djh275
5. ZETTER BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol. 1993; 4: 219-29.
6. TUCKWELL DS, WESTON SA, HUMPHRIES MJ. Integrins: a review of their structure and mechanisms of ligand binding. Symp Soc Exp Biol. 1993; 47: 107-36.
7. HYNES, R.O. Integrins: versatility, modulation and signalling in cell adhesion. Cell 1992; 69:11-25. http://dx.doi.org/10.1016/0092-8674(92)90115-S
8. DAMSKY CH, WERB Z. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol. 1992; 4: 772-81. http://dx.doi.org/10.1016/0955-0674(92)90100-Q
9. MOROZEVICH G, KOZLOVA N, CHEGLAKOV I, USHAKOVA N, BERMAN A. Integrin α5β1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity. Cell Cycle 2009; 8: 2219-2225. http://dx.doi.org/10.4161/cc.8.14.8980
10. HYNES R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-87. http://dx.doi.org/10.1016/S0092-8674(02)00971-6
11. JIA Y, ZENG ZZ, MARKWART SM, ROCKWOOD KF, IGNATOSKI KMW, et al. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res 2004; 64: 8674-81. http://dx.doi.org/10.1158/0008-5472.CAN-04-0069
12. MUNSHI HG, STACK MS. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 2006; 25: 45-56. http://dx.doi.org/10.1007/s10555-006-7888-7
13. EGEBLAD M, WERB Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74. http://dx.doi.org/10.1038/nrc745
14. CAMPBELL NE, KELLENBERGER L, GREENAWAY J, MOOREHEAD RA, LINNERTH-PETRIK NM, et al. Extracellular Matrix Proteins and Tumor Angiogenesis. Journal of Oncology 2010; 10: 1155-1167.
15. HAWINKELS LJ, KUIPER P, WIERCINSKA E, VERSPAGET HW, LIU Z, et al. Matrixmetalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 2010; 70: 4141-4150. http://dx.doi.org/10.1158/0008-5472.CAN-09-4466
16. DIA VP, GONZALEZ DE MEJIA E. Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/ NF-κB signaling. Cancer Lett 2011; 313: 167-80. http://dx.doi.org/10.1016/j.canlet.2011.09.002
17. TOQUET C, COLSON A, JARRY A, BEZIEAU S, VOLTEAU C, et al. ADAM15 to α5β1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis. Int J Cancer 2012; 130: 278-87. http://dx.doi.org/10.1002/ijc.25891
18. KIM S, KANG HY, NAM EH, CHOI MS, ZHAO XF, et al. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis 2010; 31: 597-606. http://dx.doi.org/10.1093/carcin/bgq024
19. JAYNE DG, HEATH RM, DEWHURST O, SCOTT N, GUILLOU PJ. Extracellular matrix proteins and chemoradiotherapy: alpha5beta1 integrin as a predictive marker in rectal cancer. Eur J Surg Oncol 2002; 28: 30-6.
20. KAITU'U-LINO TJ, PALMER KR, WHITEHEAD CL, WILLIAMS E, LAPPAS M, et al. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. Am J Pathol 2012; 180: 888-94. http://dx.doi.org/10.1016/j.ajpath.2011.11.014
21. HAMILTON SR, AALTONEN LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press 2000: 314p.
22. MAURO L, SISCI D, BARTUCCI M, SALERNO M, KIM J, et al. SHC-α5β1 Integrin Interactions Regulate Breast-Cancer Cell Adhesion and Motility. Experimental Cell Research 1999; 252: 439-448. http://dx.doi.org/10.1006/excr.1999.4639
23. CHIH-HSIN TANG, YUN-TING KENG, JU-FANG LIU. HMGB-1 induces cell motility and a 5b1 integrin expression in human chondrosarcoma cell. Cancer Letters 2012; 322: 98-106. http://dx.doi.org/10.1016/j.canlet.2012.02.014
24. STOELTZING O, LIU W, REINMUTH N, FAN F, PARRY GC, et al. Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer 2003; 104: 496-503. http://dx.doi.org/10.1002/ijc.10958
25. ZENG ZZ, YAO H, STASZEWSKI ED, ROCKWOOD KF, MARKWART SM, et al. α5β1 Integrin Ligand PHSR Induces Invasion and α5 mRNA in Endothelial Cells to Stimulate Angiogenesis. Translational Oncology 2009; 2: 8-20.
26. IMANISHI Y, HU B, JARZYNKA MJ, GUO P, ELISHAEV E, et al. Angiopoietin-2 Stimulates Breast Cancer Metastasis through the α5β1 Integrin-Mediated Pathway. Cancer Res 2007; 67: 4254-63. http://dx.doi.org/10.1158/0008-5472.CAN-06-4100
27. DE TONI-COSTES F, DESPEAUX M, BERTRAND J, BOUROGAA E, YSEBAERT L, et al. A Newα5β1 Integrin-Dependent Survival Pathway Through GSK3b Activation in Leukemic Cells. 2010; 5: e9807.
28. ZHANG Z, VUORI K, REED JC, RUOSLAHTI E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 Expression. Proc Natl Acad Sci USA 1995; 92: 6161-5. http://dx.doi.org/10.1073/pnas.92.13.6161
29. LEE JW, JULIANO RL. α5β1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol-3-kinase and protein kinase bB-dependent pathway. Mol Biol Cell 2000; 11: 1973-87.
30. BOUDREAU N, SYMPSON CJ, WERB Z, BISSELL MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-3. http://dx.doi.org/10.1126/science.7531366
31. CHEN TY, LI YC, LIU YF, TSAI CM, HSIEH YH, et al. Role of MMP14 Gene Polymorphisms in Susceptibility and Pathological Development to Hepatocellular Carcinoma. Ann Surg Oncol 2011; 18: 2348-2356. http://dx.doi.org/10.1245/s10434-011-1574-x
32. EGEBLAD, M., WERB, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002; 2: 161-174. http://dx.doi.org/10.1038/nrc745
33. OHUCHI E, IMAI K, FUJII Y, SATO H, SEIKI M, et al. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446-2451. http://dx.doi.org/10.1074/jbc.272.4.2446
34. D'ORTHO MP, WILL H, ATKINSON S, BUTLER G, MESSENT A, et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteo-lytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997; 250: 751-757. http://dx.doi.org/10.1111/j.1432-1033.1997.00751.x
35. SOUNNI NE, DEVY L, HAJITOU A, FRANKENNE F, MUNAUT C, et al. MT1-MMPexpression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 2002; 16: 555-564. http://dx.doi.org/10.1096/fj.01-0790com
36. ROMAN J, RITZENTHALER JD, ROSER-PAGE S, SUN X, HAN S. Alpha 5 beta1-integrin expression is essential for tumor progression in experimental lung cancer. Am J Respir Cell Mol Biol. 2010; 43: 684-691. http://dx.doi.org/10.1165/rcmb.2009-0375OC
37. DE TONI-COSTES F, DESPEAUX M, BERTRAND J, BOUROGAA E, YSEBAERT L, et al. A New a5β1 Integrin-Dependent Survival Pathway Through GSK3β Activation in Leukemic Cells. PloS ONE 2010; 5: e9807. http://dx.doi.org/10.1371/journal.pone.0009807
38. HARTNEY JM, BROWN J, CHU HW, CHANG LY, PELANDA R, et al. Arhgef1 Regulates a5β1 Integrin-Mediated Matrix Metalloproteinase Expression and Is Required for Homeostatic Lung Immunity. Am J of Pathol 2010; 176: 1157-1168. http://dx.doi.org/10.2353/ajpath.2010.090200
39. KESANAKURTI D, Chetty C, DINH DH, GUJRATI M, RAO JS. Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with a5β1 integrin in glioma. Oncogene 2012; 1-14.
40. MOROZEVICH G, KOZLOVA N, CHEGLAKOV I, USHAKOVA N, BERMAN A. Integrin α5β1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity. Cell Cycle 2009; 8: 2219-2225. http://dx.doi.org/10.4161/cc.8.14.8980
41. TETU B, BRISSON J, WANG CS, LAPOINTE H, BEAUDRY G, et al. The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Research2006; 8:R28. http://dx.doi.org/10.1186/bcr1503
42. FENG SHI, JANE SOTTILE. MT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectin. Journal of Cell Science 2011; 124: 4039-4050. http://dx.doi.org/10.1242/jcs.087858
43. YANA I, SAGARA H, TAKAKI S, TAKATSU K, NAKAMURA K, et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. Journal of Cell Science 2007; 120: 1607-1614. http://dx.doi.org/10.1242/jcs.000679